rjs - Thank you (and Buildit) for your posts. I suspect

New Post Public Reply Private Reply Replies (0) Message Board
FanMail rjs9787 #35159
652
rjs -
Thank you (and Buildit) for your posts. I suspect [strongly] that some on here believe that my motives have been negative only when it came to the success of GNBT and NuGen, and from reading the posts (especially out of context), I can see that being the impression. To give them a little context, however, it was about a year ago that I first started posting on IH, and my initial issue was the "unsanctioned" trading of NUGX on OTC, when we were told that NuGen was going to be listed on NASDAQ, and under the symbol NGIO (the symbol had been reserved the previous September, I believe). No one, including MMPJOE, however, could/would give me any information whatsoever on how NUGX started trading, and who was behind it, despite the fact that filings had to be made in order to trade, not only filed by someone named in the filing, but also containing information that seemed to me to be not readily available. The other unusual circumstance was that it was only the first tranche of the dividend shares that could be traded as NUGX on the OTX, and not the second tranche. I never could obtain an answer from anyone (again including MMPJOE) as to what that would be, and again, information that would be readily known to or ascertainable by, the CEO/Pres/CoB (and perhaps others). This was the issue that first triggered some real suspicion about what was going on with the company, and it likewise is not the kind of issue that management would be proper in telling me (either implicitly or in so many words) that it was "none of my business," as I was (and still am) a shareholder of NUGX shares.

The next issue that arose was the Last Chance for Children fundraising efforts. When I started looking more than superficially at the organization (I'll be kind, and call it that at this point), it turned out that, LCFC was organized for the purpose of curing Type 1 diabetes i children, not providing a COVID vaccine. It was readily available on guidestar.org, that rates charitable organizations. Lo and behold on the website for LCFC itself, however, was no reference at all to DM, or any cure for children. Another red flag. Once again, my posts on this issue were not well-received.

Then came the May CC, and the hoopla surrounding the AZ facility opening. In fact, that facility was supposed to have been finished, and up-and-running. There was no extrinsic (i.e., independent) evidence of that being the case, however, from any source outside GNBT. Again, no one would answer why that would be the case. Unbeknownst to me, however, time was running out to get answers, because other than a brief PR in July, the companies would "go dark" following that CC.

Along the way, and before my participation in IH, there were other events and circumstances that began to lead me to question the prudence of my investment, but like many others (still some on here, I expect), I chose to believe that these were just bumps in the proverbial road of small biotechs, and that everything eventually would get sorted, especially with someone at the helm who appeared to demonstrate a true dedication to both the investors as well as the goals of the companies. As we know now, of course, it was a matter of "all sizzle, no steak" sold to us by a clever person who appealed both to our vanity ("loyal shareholders" and our own desire to be a part of something that would benefit many others.

So now, like hylander and others, I am infuriated by the cowardice exhibited by the CEO/Pres/CoB, who will not step forward and tell us what happened. And did you ever notice that Joe never personally told anyone that he or GNBT was subject to an actual gag order? That was the inference some drew, and who was he to kill that rumor? If he actually had announced that there was such an order, then anyone could go to the source to confirm it, and if it were not true, that in itself would be defrauding investors. And before anyone is inspired to respond by saying "maybe Joe can't tell anyone that he is not allowed to tell anyone," think about just how foolish that remark would be in the context of a fiduciary's legal obligations.

I agree with NYD and others that there are bad tidings coming, because bad things have been happening. When lawyers tell clients not to talk to anyone, it is for a reason; usually, it is for multiple reasons. I am not looking for a "pound of flesh" from the CEO, but I am looking forward to the exposure of the truth.

Oh, and before I forget -

quack, quack, paddle, paddle, waddle, waddle.

Have a safe and relaxing weekend, and pray for those affected by the Ukraine invasion.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Memoir 'Pinball' Explores Life's Unpredictable Momentum

Updated Category News Views 40

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Continue Reading
YR Fitness Rolls Out Innovator's Iron at FIBO 2027

Updated Category News Views 73

A New Era of Strength Training Equipment? That's the question I asked myself when I heard about YR Fitness showcasing their latest gym gear at FIBO 2027. This isn't just another batch of machines rolling off the production line. YR Fitness has become quite the icon in China for strength equipment, and they're dead set on shaking up the market in Cologne, Germany from...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 93

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 133

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
Alfa Laval's Market Outlook: Strategic Plans Ahead

Updated Category News Views 0

Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...

Continue Reading
ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 42

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
WareSpace Expands in U.S. with Key Site Acquisitions

Updated Category News Views 90

WareSpace's National Growth Strategy: A New Expansion Chapter They say everything's bigger in Texas, but WareSpace is showing that smaller can be mighty impactful too. With its shrewd acquisition of sites in Houston's Inner Loop and Fremont's Warm Springs corridor, WareSpace is playing it smart, appeasing that roaring demand for tiny but mighty warehouse spaces across...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 23

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
Kia's Thunderous October Sales Surge: What's Under the Hood?

Updated Category News Views 120

Electric Pulse: Kia's Electrified Dreams Soar No one said the road to the top is easy, yet Kia America is cruising along with six straight months of shattering sales records. October's monumental figures paint the picture clear as a bell — 80,008 units dispatched to eager drivers, with electrified and hybrid models zooming to new heights. It ain't just the same old...

Continue Reading
TEKLYNX 2026: Revolutionizing Barcode Labeling Tech

Updated Category News Views 55

In the ever-evolving world of supply chain technology, a big move by TEKLYNX is making waves. The 2026 version of their barcode labeling software isn't just an upgrade—it's a full-blown transformation. They've fine-tuned their suite to align with the latest industry standards and integrated fresh capabilities that scream future-proofing. TEKLYNX's Game-Changing Upgrades...

Continue Reading

Top 5 Most Recently Viewed Articles

Tsubame BHB Recognized for Pioneering Ammonia Solutions Globally

Updated Category News Views 169

Tsubame BHB Earns Recognition in Global Cleantech Innovation Tsubame BHB Co., Ltd. has recently made headlines for being named one of the standout companies in the 2025 Global Cleantech 100 list, an accolade that underscores its innovative approach to ammonia manufacturing. This recognition highlights the company's commitment to harnessing low-temperature and low-pressure...

Continue Reading
Transforming $1000 into a Wealthy Investment with ONTO

Updated Category News Views 67

Smart Investment Growth: The Rise of Onto Innovation In the last five years, Onto Innovation (NYSE: ONTO) has emerged as a remarkable player in the stock market, significantly surpassing average market gains. With an impressive annualized return of 42.16%, those who invested in ONTO have experienced extraordinary growth. The Power of Compound Returns Understanding...

Continue Reading
Celebrating Dr. Beatrice Setnik: A PharmaVoice 100 Honoree

Updated Category News Views 222

Dr. Beatrice Setnik Honored as PharmaVoice 100 Winner Altasciences is thrilled to share that Dr. Beatrice Setnik has been honored as a PharmaVoice 100 winner. With almost two decades of expertise in clinical drug development, especially regarding abuse potential studies, Dr. Setnik's leadership qualities have made a notable impact in the field. As the Chief Scientific...

Continue Reading
Momentus Secures Major Defense Contract and Financing Boost

Updated Category News Views 171

Momentus Inc Achieves Significant Milestone Momentus Inc (NASDAQ: MNTS) has recently made headlines with a notable increase in its stock value after the company secured inclusion in a crucial defense contract program in the U.S. This achievement not only highlights the strategic importance of the company’s offerings but also brings in new opportunities for growth as...

Continue Reading
HCI Group's Remarkable Q2 2025 Financial Highlights Explained

Updated Category News Views 137

Exceptional Financial Results for HCI Group in Q2 2025 HCI Group, Inc. (NYSE:HCI) has reported outstanding financial performance for the second quarter of 2025, showcasing remarkable metrics that highlight its commitment to profitability and shareholder value. With a pre-tax income of $94.4 million and a net income of $70.3 million, up from $54.1 million in the second...

Continue Reading